Nektar Therapeutics (NKTR) had the lowest return in February 2023 by a mid-cap US stock, returning -49.6%.
| ASSET | MONTH | % RETURN |
|---|---|---|
Nektar Therapeutics (NKTR) | February 2023 | -49.64% |
D-Wave Quantum (QBTS) | February 2023 | -44.4% |
Praxis Precision Medicines (PRAX) | February 2023 | -38.58% |
LYFT (LYFT) | February 2023 | -38.42% |
Immunitybio (IBRX) | February 2023 | -35.79% |
Lumen Technologies (LUMN) | February 2023 | -35.61% |
Hycroft Mining (HYMC) | February 2023 | -35.17% |
Opendoor Technologies (OPEN) | February 2023 | -34.25% |
Terawulf (WULF) | February 2023 | -34.2% |
Wayfair (W) | February 2023 | -33.45% |
VNET Group Inc DRC (VNET) | February 2023 | -33.05% |
Twist Bioscience (TWST) | February 2023 | -32.94% |
Vicor (VICR) | February 2023 | -32.35% |
Xp (XP) | February 2023 | -30.19% |
Soleno Therapeutics (SLNO) | February 2023 | -30% |
Scholar Rock (SRRK) | February 2023 | -29.38% |
Bill Com (BILL) | February 2023 | -27.38% |
AXT (AXTI) | February 2023 | -26.31% |
Inter & Co Inc Class A Common Shares (INTR) | February 2023 | -26.18% |
Capri (CPRI) | February 2023 | -25.69% |
Relay Therapeutics (RLAY) | February 2023 | -24.5% |
StoneCo (STNE) | February 2023 | -24.09% |
Kingsoft Cloud Holdings (KC) | February 2023 | -23.76% |
Sirius XM (SIRI) | February 2023 | -23.55% |
Sibanye Gold Ltd ADR (SBSW) | February 2023 | -23.22% |
Mid-cap stocks are treated as having a market cap between $2B and $10B.
